WO1999012888A1 - Method for producing aryloligoamines - Google Patents
Method for producing aryloligoamines Download PDFInfo
- Publication number
- WO1999012888A1 WO1999012888A1 PCT/EP1998/005398 EP9805398W WO9912888A1 WO 1999012888 A1 WO1999012888 A1 WO 1999012888A1 EP 9805398 W EP9805398 W EP 9805398W WO 9912888 A1 WO9912888 A1 WO 9912888A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- palladium
- aryl
- groups
- different
- atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- UHOVQNZJYSORNB-UHFFFAOYSA-N c1ccccc1 Chemical compound c1ccccc1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 11
- 0 CC(*)c1cc(C)c2-c3ccc(C)cc3C3(c4cc(C)cc(C)c4-c4ccc(C)cc34)c2c1 Chemical compound CC(*)c1cc(C)c2-c3ccc(C)cc3C3(c4cc(C)cc(C)c4-c4ccc(C)cc34)c2c1 0.000 description 1
- ZYJOYVNQLVMSSC-UHFFFAOYSA-N CC(C1)C=CC2=C1C1(c3cc(C)cc(C)c3-c3ccc(C)cc13)c1cc(C)cc(C)c21 Chemical compound CC(C1)C=CC2=C1C1(c3cc(C)cc(C)c3-c3ccc(C)cc13)c1cc(C)cc(C)c21 ZYJOYVNQLVMSSC-UHFFFAOYSA-N 0.000 description 1
- ODLMAHJVESYWTB-UHFFFAOYSA-N CCCc1ccccc1 Chemical compound CCCc1ccccc1 ODLMAHJVESYWTB-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/04—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
- C07C209/06—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of halogen atoms
- C07C209/10—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of halogen atoms with formation of amino groups bound to carbon atoms of six-membered aromatic rings or from amines having nitrogen atoms bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/615—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/631—Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/93—Spiro compounds
- C07C2603/94—Spiro compounds containing "free" spiro atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E10/00—Energy generation through renewable energy sources
- Y02E10/50—Photovoltaic [PV] energy
- Y02E10/549—Organic PV cells
Definitions
- aryl oligoamines which have several amine units
- they can be used as hole conductors in xerography (see, for example, PM Borsenberger, DS Weiss, Organic Photoreceptors for Imaging Systems, Marcel Dekker, Inc.), in organic electroluminescent devices (see, for example, JJ Kido, Bull. Electrochem. 1994, 10, 1-13; DE-A-197 11 714) and dye-sensitized photovoltaic cells (see, for example, DE-A 197 1 1 714).
- Aryloligoamines are generally built up via variants of the Ullmann reaction (J. March. Adv. Org. Chem. 4th Ed., P. 665, John Wiley & Sons, New York 1992). For example, the representation of 4,4 ', 4 "tris (N, N-diphenylamino) triphenylamine (Shirota et al., Chem. Lat. 1989, 1 145-1 148) and tris
- aryl oligoamines In general, the production of aryl oligoamines is more difficult than that of aryl monoamines.
- Ullmann reactions can be carried out under optimal conditions with a yield of about 80%. Applying this to a tri or
- aryloligoamines can be prepared simply and in good yields by directly coupling a primary or secondary amine with an activated aromatic in the presence of a base, a palladium component and a phosphine ligand.
- the invention therefore relates to a process for the preparation of aryloligoamines, characterized in that an amine with an activated
- aryloligoamine means a compound which contains at least two amine units bonded to aromatic groups.
- Preferred starting compounds are activated aromatics of the general formula (I),
- A is an aromatic and / or heteroaromatic radical with 2 to 200 carbon atoms, which may contain several aromatic and / or heteroaromatic groups, such groups then condensing (for example Anthracene, triphenylene) or uncondensed (for example biphenyl, terphenyl, 1, 3,5-triphenylbenzene);
- R ⁇ R 2 are identical or different H, CN, C r C 12 alkyl, C 4 -C 10 aryl;
- R 3 , R 4 are identical or different C r C 12 alkyl, C 4 -C 10 aryl;
- R 5 is CC 12 alkyl, C 4 -C 10 aryl
- X is Cl, Br, I, mesylate, tosylate or C 1 -C 12 perfluoroalkyl sulfonate;
- m is a natural number, where 2 ⁇ m ⁇ y;
- n is a natural number, where 0 ⁇ n ⁇ y-m;
- y is the number of free valences on the base body A
- R is the same or different NO 2 , CN, F, an unbranched or branched alkyl group with 1 to 22 C atoms.
- A is benzene, naphthalene, anthracene, pyrene, triphenylene, biphenyl, fluorene, terphenyl, 1, 3,5-triphenylbenzene, spiro-9,9'-bifluorene, 2,2 ', 7,7'-tetraphenylspiro-9,9 '-bifluoren, 2,2', 7,7'-tetra (4'-biphenylyl) spiro-9,9'-biphenyl, 2,4,7,2'4, 7'-Hexaphenylspiro-9,9, -bifluoren and 2,4,7,2, 4 ', 7'-hexa (4'-biphenylyl) spiro-9,9'-bifluorene or other oligophenylene- substituted derivative of the spiro-9,9'-bifluorens;
- R is the same or different NO 2 , CN, F, an unbranched or branched alkyl group with 1 to 22 C atoms.
- X is Br, I
- n 4, 5 or 6
- n 0, 1, 2, 3, 4, 5, 6.
- Particularly preferred activated aromatics of the formula (I) are those of the formula (Ia)
- X is the same or different, Br, I or H and k, l, p, q, r, s 0, 1, 2, 3, 4, with the proviso that at least two, preferably at least four, of the radicals X Br or I are.
- Preferred amine components are those of the formula (II)
- the ratio of the starting materials is not critical and can therefore be varied within a wide range, a ratio of activated group to amine of 1: 0.8 to 2, particularly preferably 1: 1 to 1.5, is preferred.
- the starting compounds, amine and activated aromatic are converted into an aryloligoamine in a coupling reaction.
- the amine, the activated aromatic, a base and catalytic amounts of a phosphine ligand are contained
- Palladium catalyst or a palladium salt and a phosphane are taken up in a solvent and at a temperature of 0 ° C to 150 ° C, preferably at 30 ° C to 140 ° C, particularly preferably at 50 ° C to 120 ° C, particularly preferably at 80 ° C to 120 ° C for a period of 1 h to 200 h, preferably 5 h to 100 h, particularly preferably 10 h to 80 h, implemented.
- the process according to the invention is generally carried out in a solvent, an excess of the base or of a starting material, preferably the amine component, also being able to serve as such a solvent.
- organic solvents or a mixture of water and one or more organic solvents is preferred, in which case at least one of the organic solvents should preferably be water-insoluble.
- Preferred organic solvents are ethers, e.g. B. diethyl ether, dimethoxymethane, diethylene glycol dimethyl ether, tetrahydrofuran, dioxane, dioxolane, diisopropyl ether, tert-butyl methyl ether, hydrocarbons, e.g. B. hexane, iso ⁇
- alcohols e.g. B. methanol, ethanol, 1-propanol, 2-propanol, ethylene glycol, 1-butanol, 2-butanol, tert-butanol, ketones, e.g. B. acetone,
- organic solvents are ethers, such as dimethoxyethane, diethylene glycol dimethyl ether, tetrahydrofuran, dioxane, diisopropyl ether, hydrocarbons, such as hexane, heptane, cyclohexane, toluene, xylene, alcohols, such as methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, tert-butanol,
- Ethylene glycol ketone, iso-butyl methyl ketone, amides such as Dimethylformamide, dimethylacetamide, N-methylpyrrolidone, and mixtures thereof.
- organic solvents are ethers, e.g. B. dimethoxyethane, tetrahydrofuran, dioxane, hydrocarbons, e.g. B. cyclohexane,
- water and organic solvents examples are mixtures of water and toluene and water, toluene and tetrahydrofuran.
- Bases which are preferably used in the process according to the invention are alkali and alkaline earth metal hydroxides, alkali and
- Provided excess can also act as a base.
- Alkali and alkaline earth metal hydroxides, alkali and alkaline earth metal carbonates and alkali and alkaline earth metal alcoholates are particularly preferred.
- Alkali metal hydroxides such as sodium hydroxide and, are particularly preferred.
- Potassium hydroxide and alkali and alkaline earth metal alcoholates, such as sodium ethanolate and sodium or potassium tert-butoxide.
- the base is preferably present in a proportion of 50 to 500 mol%, particularly preferably 50 to 250 mol%, very particularly preferably 75 to 200 mol%, in particular 90 to 120 mol%, based on the moles present NH, used.
- the palladium component contains palladium metal or a palladium (0) or (II)
- Palladium component and phosphine ligand can be used as a complex, for example as the preferred Pd (PPh 3 ) 4 , or separately.
- Suitable palladium components are, for example, palladium compounds, such as palladium ketonates, palladium acetylacetonates, nitrile palladium halides,
- Palladium can also serve as a palladium component in metallic form, hereinafter only called palladium, preferably palladium in powdered form or on a support material, for example palladium on activated carbon, palladium on aluminum oxide, palladium on barium carbonate, palladium on barium sulfate, palladium on aluminum silicates, such as montmorillonite, Palladium on SiO 2 and
- Palladium on calcium carbonate each with a palladium content of 0.5 to 10 wt .-%.
- Palladium on activated carbon with a palladium content of is particularly preferred
- the palladium component is used in a proportion of 0.01 to 10 mol%, preferably 0.05 to 5 mol%, particularly preferably 0.1 to 3 mol%, particularly preferably 0.1 to 1.5 Mol%, based on the N-
- Suitable phosphine ligands for the process according to the invention are, for example, trialkylphosphines, tricycloalkylphosphanes, triarylphosphines, where the three substituents on the phosphorus can be the same or different, chiral or achiral and one or more of the ligands can link the phosphorus groups of several phosphines and part of this linkage also includes or can be several metal atoms.
- phosphanes which can be used in the process according to the invention are trimethylphosphine, tributylphosphine, tricyclohexylphosphine, triphenylphosphine, tritolylphosphine, tris (4-dimethylaminophenyl) phosphine, bis (diphenylphosphano) methane, 1,2-bis (diphenylphosphano) ethane, 1,3
- Triphenylphosphine tris (o-tolyl) phosphane, 1,2-bis (diphenylphosphano) ethane, 1,3-bis (diphenylphosphano) propane and 1,1'-bis (diphenylphosphano) ferrocene, especially triphenylphosphane and tris, are very particularly preferred (o-tolyl) phosphine.
- water-soluble phosphine ligands which contain, for example, sulfonic acid salt and / or sulfonic acid residues and / or carboxylic acid salt and / or carboxylic acid residues and / or phosphonic acid salt and / or phosphonic acid residues and / or phosphonium groups and / or peralkylammonium groups and / or hydroxyl groups and / or Contain polyether groups with a suitable chain length.
- Preferred classes of water-soluble phosphine ligands are trialkylphosphines substituted with the above groups, tricycloalkylphosphanes, triarylphosphines,
- the phosphine ligand is used in a proportion of 0.1 to 20 mol%, preferably 0.2 to 15 mol%, particularly preferably 0.5 to 10 mol%, particularly preferably 1 to 6 mol%, based on the NH present - Groups.
- Mixtures of two or more different phosphine ligands can optionally also be used.
- the products of the method according to the invention are e.g. for use in electroluminescent devices, dye-sensitized photovoltaic cells or in xerography, for example as hole conductor materials.
- Example 1 implemented. DPPF was used as the ligand.
- the workup was also carried out analogously, but the product proved to be significantly more difficult to clean.
- the mixture was first filtered twice over a silica gel column and then initially recrystallized from ethyl acetate / methanol (2: 1), then repeatedly from dioxane. After drying, 26% product was obtained (purity:> 99.9% according to HPLC).
- Example 2 implemented. The processing was also carried out analogously. After drying, 31% of product was obtained (purity:> 99.7% according to HPLC).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
Beschreibungdescription
Verfahren zur Herstellung von AryloligoaminenProcess for the preparation of aryl oligoamines
Aryl- und Heteroarylderivate, welche mehrere Amineinheiten aufweisen (im folgenden Aryloligoamine), sind seit längerem in verschiedenartigen Anwendungen im Einsatz. So können sie beispielsweise als Lochleiter in der Xerographie (siehe z.B. P. M. Borsenberger, D. S. Weiss, Organic Photoreceptors for Imaging Systems, Marcel Dekker, Inc.), in organischen Elektrolumineszenzvorrichtungen (siehe, z. B. J. Kido, Bull. Electrochem. 1994, 10, 1-13; DE-A- 197 11 714) und farbstoffsensibilisierten photovoltaischen Zellen (siehe z.B. DE-A 197 1 1 714) Verwendung finden.Aryl and heteroaryl derivatives, which have several amine units (hereinafter aryl oligoamines), have long been used in various applications. For example, they can be used as hole conductors in xerography (see, for example, PM Borsenberger, DS Weiss, Organic Photoreceptors for Imaging Systems, Marcel Dekker, Inc.), in organic electroluminescent devices (see, for example, JJ Kido, Bull. Electrochem. 1994, 10, 1-13; DE-A-197 11 714) and dye-sensitized photovoltaic cells (see, for example, DE-A 197 1 1 714).
Als besonders interessant haben sich dabei unter anderem Derivate des Spirobifluorens erwiesen (siehe z.B. DE-A 197 11714).Derivatives of spirobifluorene, among others, have proven to be particularly interesting (see e.g. DE-A 197 11714).
Aryloligoamine werden in der Regel über Varianten der Ullmann-Reaktion ( J. March. Adv. Org. Chem. 4th Ed., S. 665, John Wiley & Sons, New York 1992) aufgebaut. So wird die Darstellung von beispielsweise 4,4',4"-Tris(N,N- diphenylamino)triphenylamin (Shirota et al., Chem.Lett. 1989, 1 145-1 148) und Tris-Aryloligoamines are generally built up via variants of the Ullmann reaction (J. March. Adv. Org. Chem. 4th Ed., P. 665, John Wiley & Sons, New York 1992). For example, the representation of 4,4 ', 4 "tris (N, N-diphenylamino) triphenylamine (Shirota et al., Chem. Lat. 1989, 1 145-1 148) and tris
(4-phenoxazin-10-yl-phenyl)-amin (Higuchi et al., Mol.Cryst.üq.Cryst. 1994, 242, 127-134) über diese Route beschrieben. Auch zur Herstellung von Lochleitern auf Basis von Spiroverbindungen, wie N,N,N,,N,,N",N",N,",N,"-Octaphenylspiro-9,9'- bifluoren-2,2',7,7'-tetramin (Salbeck et al., Book of Abstracts, 213th ACS National Meeting, San Francisco 1997, 199) ist diese Reaktion beschrieben.(4-phenoxazin-10-yl-phenyl) amine (Higuchi et al., Mol.Cryst.üq.Cryst. 1994, 242, 127-134) via this route. For the production of hole conductors based on spiro compounds such as N, N, N, N, N ', N ", N", N "-Octaphenylspiro-9,9'-bifluoren-2,2', 7 , 7'-tetramine (Salbeck et al., Book of Abstracts, 213 th ACS National Meeting, San Francisco 1997, 199) describes this reaction.
Allgemein gilt, daß die Herstellung von Aryloligoaminen gegenüber der von Arylmonoaminen erhöhte Schwierigkeiten mit sich bringt. So ist z.B. bekannt, daß Ullmann-Reaktionen unter optimalen Bedingungen mit ca. 80% Ausbeute durchgeführt werden können. Wendet man dies auf eine Tri- oderIn general, the production of aryl oligoamines is more difficult than that of aryl monoamines. For example, known that Ullmann reactions can be carried out under optimal conditions with a yield of about 80%. Applying this to a tri or
Tetrakupplungsreaktion an, so kommt man bereits theoretisch nur noch auf 51 bzw. 41 % Ausbeute, was zum einen die Wirtschaftlichkeit beeinträchtigt, zum anderen die Reinigung der Produkte erschwert.Tetra coupling reaction arrives, so theoretically only 51 or 41% yield, which on the one hand affects the economy and on the other hand makes cleaning the products more difficult.
Es wurde nun überraschend gefunden, daß sich Aryloligoamine einfach und in guten Ausbeuten durch direkte Kupplung eines primären oder sekundären Amins mit einem aktivierten Aromaten in Gegenwart einer Base, einer Palladiumkomponente und eines Phosphanliganden herstellen lassen.It has now surprisingly been found that aryloligoamines can be prepared simply and in good yields by directly coupling a primary or secondary amine with an activated aromatic in the presence of a base, a palladium component and a phosphine ligand.
Ein ähnliches Verfahren ist zwar aus der US-A 5,576,460 bekannt, es ist dort allerdings ausschließlich zur Darstellung von Arylmonoaminen beschrieben.A similar process is known from US Pat. No. 5,576,460, but it is only described there for the preparation of aryl monoamines.
Zudem wird im einzigen Beispiel eine Ausbeute von lediglich 75 % erhalten, wodurch der Fachmann zu dem Schluß kommt, daß eine solche Methode zum Aufbau von Aryloligoaminen weniger geeignet ist als die Ullmann-Reaktion. Gegenstand der Erfindung ist daher ein Verfahren zur Herstellung von Aryloligoaminen, dadurch gekennzeichnet, daß man ein Amin mit einem aktiviertenIn addition, a yield of only 75% is obtained in the only example, which leads the person skilled in the art to conclude that such a method for building up aryloligoamines is less suitable than the Ullmann reaction. The invention therefore relates to a process for the preparation of aryloligoamines, characterized in that an amine with an activated
Aromaten und einer Base in einem Temperaturbereich von 0 bis 150°C in Gegenwart einer Palladiumkomponente und eines Phosphanliganden umsetzt.Aromatics and a base in a temperature range from 0 to 150 ° C in the presence of a palladium component and a phosphine ligand.
Aryloligoamin bedeutet im Sinne der Erfindung eine Verbindung, die mindestens zwei an aromatische Gruppen gebundene Amineinheiten enthält.For the purposes of the invention, aryloligoamine means a compound which contains at least two amine units bonded to aromatic groups.
Bevorzugte Ausgangsverbindungen sind aktivierte Aromaten der allgemeinen Formel (I),Preferred starting compounds are activated aromatics of the general formula (I),
(R)n-A-(X)m (I)(R) n -A- (X) m (I)
wobei die Symbole und Indizes folgende Bedeutung haben:where the symbols and indices have the following meaning:
A ist ein aromatischer und/oder heteroaromatischer Rest mit 2 bis 200 C- Atomen, der mehrere aromatische und/oder heteroaromatische Gruppen enthalten kann, wobei solche Gruppen dann kondensiert (beispielsweise Anthracen, Triphenylen) oder unkondensiert (beispielsweise Biphenyl, Terphenyl, 1 ,3,5-Triphenylbenzol) sind;A is an aromatic and / or heteroaromatic radical with 2 to 200 carbon atoms, which may contain several aromatic and / or heteroaromatic groups, such groups then condensing (for example Anthracene, triphenylene) or uncondensed (for example biphenyl, terphenyl, 1, 3,5-triphenylbenzene);
R ist gleich oder verschieden NO2, CN, F, eine unverzweigte oder verzweigte Alkylgruppe mit 1 bis 22 C-Atomen, wobei eine oder mehrere CH2-Gruppen durch -O- , -S- , -CO- , -O-CO- , -CO-O- , -O-CO-O- , -CR1=CR2 , -C≡C- , SiR3R4 , C4-C10-Aryldiyl , C4-C10-Heteroaryldiyl, Cyclohexylen, -NR5- ersetzt sein können, wobei Heteroatome nicht direkt aneinander geknüpft sein dürfen, und wobei ein oder mehrere H-Atome durch F, Cl, Br ersetzt sein können;R is the same or different NO 2 , CN, F, an unbranched or branched alkyl group having 1 to 22 C atoms, one or more CH 2 groups being represented by -O-, -S-, -CO-, -O-CO -, -CO-O-, -O-CO-O-, -CR 1 = CR 2 , -C ≡ C-, SiR 3 R 4 , C 4 -C 10 aryldiyl, C 4 -C 10 heteroaryldiyl, Cyclohexylene, -NR 5 - can be replaced, wherein heteroatoms must not be directly linked to one another, and one or more H atoms can be replaced by F, Cl, Br;
R\ R2 sind gleich oder verschieden H, CN, CrC12-Alkyl, C4-C10-Aryl;R \ R 2 are identical or different H, CN, C r C 12 alkyl, C 4 -C 10 aryl;
R3, R4 sind gleich oder verschieden CrC12-Alkyl, C4-C10-Aryl;R 3 , R 4 are identical or different C r C 12 alkyl, C 4 -C 10 aryl;
R5 ist C C12-Alkyl, C4-C10-Aryl;R 5 is CC 12 alkyl, C 4 -C 10 aryl;
X ist Cl, Br, I, Mesylat, Tosylat oder C1-C12-Perfluoralkylsulfonat;X is Cl, Br, I, mesylate, tosylate or C 1 -C 12 perfluoroalkyl sulfonate;
m ist eine natürliche Zahl, wobei gilt 2 < m < y;m is a natural number, where 2 <m <y;
n ist eine natürliche Zahl, wobei gilt 0 < n < y-m;n is a natural number, where 0 <n <y-m;
y ist die Zahl der freien Valenzen am Grundkörper A;y is the number of free valences on the base body A;
Vorzugsweise haben die Symbole und Indizes in der Formel (I) folgende Bedeutungen:The symbols and indices in the formula (I) preferably have the following meanings:
R ist gleich oder verschieden NO2, CN, F, eine unverzweigte oder verzweigte Alkylgruppe mit 1 bis 22 C-Atomen.R is the same or different NO 2 , CN, F, an unbranched or branched alkyl group with 1 to 22 C atoms.
X Cl, Br, I, Tosylat; m 3 < m < y;X Cl, Br, I, tosylate; m 3 <m <y;
Besonders bevorzugt haben die Symbole und Indizes in der Formel (I) folgende Bedeutungen:The symbols and indices in the formula (I) particularly preferably have the following meanings:
A ist Benzol, Naphthalin, Anthracen, Pyren, Triphenylen, Biphenyl, Fluoren, Terphenyl, 1 ,3,5-Triphenylbenzol, Spiro-9,9'-bifluoren, 2,2',7,7'- Tetraphenylspiro-9,9'-bifluoren, 2,2',7,7'-Tetra(4'-biphenylyl)spiro-9,9'- biphenyl, 2,4,7,2'4,,7'-Hexaphenylspiro-9,9,-bifluoren und 2,4,7,2,,4',7'- Hexa(4'-biphenylyl)spiro-9,9'-bifluoren oder ein anderes Oligophenylen- substituiertes Derivat des Spiro-9,9'-bifluorens;A is benzene, naphthalene, anthracene, pyrene, triphenylene, biphenyl, fluorene, terphenyl, 1, 3,5-triphenylbenzene, spiro-9,9'-bifluorene, 2,2 ', 7,7'-tetraphenylspiro-9,9 '-bifluoren, 2,2', 7,7'-tetra (4'-biphenylyl) spiro-9,9'-biphenyl, 2,4,7,2'4, 7'-Hexaphenylspiro-9,9, -bifluoren and 2,4,7,2, 4 ', 7'-hexa (4'-biphenylyl) spiro-9,9'-bifluorene or other oligophenylene- substituted derivative of the spiro-9,9'-bifluorens;
R ist gleich oder verschieden NO2, CN, F, eine unverzweigte oder verzweigte Alkylgruppe mit 1 bis 22 C-Atomen.R is the same or different NO 2 , CN, F, an unbranched or branched alkyl group with 1 to 22 C atoms.
X ist Br, I ;X is Br, I;
m ist 4, 5 oder 6 undm is 4, 5 or 6 and
n ist 0, 1 , 2, 3, 4, 5, 6. n is 0, 1, 2, 3, 4, 5, 6.
Insbesondere bevorzugte aktivierte Aromaten der Formel (I) sind solche der Formel (la)Particularly preferred activated aromatics of the formula (I) are those of the formula (Ia)
wobei X gleich oder verschieden, Br, I oder H und k,l,p,q,r,s 0, 1 , 2, 3, 4 bedeuten, mit der Maßgabe, daß mindestens zwei, vorzugsweise mindestens vier, der Reste X Br oder I sind. where X is the same or different, Br, I or H and k, l, p, q, r, s 0, 1, 2, 3, 4, with the proviso that at least two, preferably at least four, of the radicals X Br or I are.
Bevorzugte Aminkomponenten sind solche der Formel (II),Preferred amine components are those of the formula (II)
wobei die Symbole folgende Bedeutungen haben:where the symbols have the following meanings:
R7, R8 sind gleich oder verschieden a) H; b) eine geradkettige, verzweigte oder cyclische Alkylgruppe mit 1 bis 22 C- Atomen, wobei eine oder mehrere CH2-Gruppen durch -O- , -S- , -CO- , -O- CO- , -CO-O- , -O-CO-O- , -CR1=CR2 , -C≡C- , SiR3R4 , C4-C10-Aryldiyl , C4-C10-Heteroaryldiyl, Cyclohexylen, -NR5- , wobei Heteroatome nicht direkt aneinander geknüpft sein dürfen, und wobei ein oder mehrere H-Atome durch F, Cl, Br ersetzt sein können; wobei R1 bis R5 die in der Formel (I) angegebenen Bedeutungen haben; c) eine C4-C12-Aryl- oder Heteroarylgruppe die durch einen oder mehrere Reste R substituiert sein kann, wobei R gleich oder verschieden die in der Formel (I) angegebenen Bedeutungen hat.R 7 , R 8 are identical or different a) H; b) a straight-chain, branched or cyclic alkyl group with 1 to 22 carbon atoms, one or more CH 2 groups being replaced by -O-, -S-, -CO-, -O- CO-, -CO-O-, -O-CO-O-, -CR 1 = CR 2 , -C≡C-, SiR 3 R 4 , C 4 -C 10 aryldiyl, C 4 -C 10 heteroaryldiyl , Cyclohexylene, -NR 5 -, where heteroatoms must not be directly linked to one another, and where one or more H atoms can be replaced by F, Cl, Br; wherein R 1 to R 5 have the meanings given in the formula (I); c) a C 4 -C 12 aryl or heteroaryl group which can be substituted by one or more radicals R, where R has the same or different meanings given in the formula (I).
Endprodukte des erfindungsgemäßen Verfahrens sowie deren Bevorzugungen ergeben sich aus den Edukten und deren Bevorzugungen.End products of the process according to the invention and their preferences result from the starting materials and their preferences.
Die Edukte des Verfahrens sind prinzipiell bekannt und entweder kommerziell erhältlich oder nach bekannten, dem Fachmann geläufigen Methoden, wie sie beispielsweise in Houben-Weyl, Methoden der Organischen Chemie, Georg ThiemeThe starting materials of the process are known in principle and are either commercially available or according to known methods known to those skilled in the art, such as, for example, in Houben-Weyl, Methods of Organic Chemistry, Georg Thieme
Verlag, Stuttgart, aufgeführt sind, herstellbar.Verlag, Stuttgart, can be produced.
Das Verhältnis der Edukte ist nicht kritisch und kann daher in weiterem Rahmen variiert werden, bevorzugt ist ein Verhältnis aktivierte Gruppe zu Amin von 1 : 0,8 bis 2, besonders bevorzugt 1 : 1 bis 1 ,5.The ratio of the starting materials is not critical and can therefore be varied within a wide range, a ratio of activated group to amine of 1: 0.8 to 2, particularly preferably 1: 1 to 1.5, is preferred.
Erfmdungsgemäß werden die Ausgangsverbindungen, Amin und aktivierter Aromat, in einer Kupplungsreaktion zu einem Aryloligoamin umgesetzt.According to the invention, the starting compounds, amine and activated aromatic, are converted into an aryloligoamine in a coupling reaction.
Zur Durchführung der Reaktion werden das Amin, der aktivierte Aromat, eine Base und katalytische Mengen eines Phosphanliganden enthaltendenTo carry out the reaction, the amine, the activated aromatic, a base and catalytic amounts of a phosphine ligand are contained
Palladiumkatalysators bzw. ein Palladiumsalz und ein Phosphan in einem Lösungsmittel aufgenommen und bei einer Temperatur von 0°C bis 150°C, bevorzugt bei 30°C bis 140° C, besonders bevorzugt bei 50°C bis 120°C, insbesondere bevorzugt bei 80°C bis 120°C für einen Zeitraum von 1 h bis 200 h, bevorzugt 5 h bis 100 h, besonders bevorzugt 10 h bis 80 h, umgesetzt. DiePalladium catalyst or a palladium salt and a phosphane are taken up in a solvent and at a temperature of 0 ° C to 150 ° C, preferably at 30 ° C to 140 ° C, particularly preferably at 50 ° C to 120 ° C, particularly preferably at 80 ° C to 120 ° C for a period of 1 h to 200 h, preferably 5 h to 100 h, particularly preferably 10 h to 80 h, implemented. The
Aufarbeitung erfolgt nach an sich bekannten, dem Fachmann geläufigen Methoden, beispielsweise durch Hydrolyse, Ausrühren, Phasenseparation und Abziehen des Lösungsmittels. Bevorzugt wird auch die Palladium-Komponente durch Ausrühren mit einem Komplexbildner entfernt. Hier eignet sich unter anderem Cyanid, Thiocyanat u.a.. Das Rohprodukt kann dann nach dem Fachmann bekannten und dem jeweiligenWorking up is carried out according to methods known per se and familiar to the person skilled in the art, for example by hydrolysis, stirring, phase separation and removal of the solvent. The palladium component is also preferably removed by stirring with a complexing agent. Cyanide, thiocyanate and others are suitable here. The crude product can then according to the person skilled in the art and the particular
Produkt angemessenen Methoden, z.B. durch Umkristallisation, Destillation, Sublimation, Zonenschmelzen, Schmelzkristallisation oder Chromatographie, aufgereinigt werden.Appropriate methods, e.g. by recrystallization, distillation, sublimation, zone melting, melt crystallization or chromatography.
Das erfindungsgemäße Verfahren wird im allgemeinen in einem Lösungsmittel durchgeführt, wobei auch ein Überschuß der Base oder eines Edukts, vorzugsweise der Aminkomponente, als solches Lösungsmittel dienen kann.The process according to the invention is generally carried out in a solvent, an excess of the base or of a starting material, preferably the amine component, also being able to serve as such a solvent.
Bevorzugt ist die Verwendung eines oder mehrerer organischer Lösungsmittel oder einer Mischung aus Wasser und einem oder mehreren organischen Lösungsmitteln, wobei in diesem Fall vorzugsweise mindestens eines der organischen Lösungsmittel wasserunlöslich sein sollte.The use of one or more organic solvents or a mixture of water and one or more organic solvents is preferred, in which case at least one of the organic solvents should preferably be water-insoluble.
Bevorzugte organische Lösungsmittel sind Ether, z. B. Diethylether, Dimethoxymethan, Diethylenglykoldimethylether, Tetrahydrofuran, Dioxan, Dioxolan, Diisopropylether, tert.-Butylmethylether, Kohlenwasserstoffe, z. B. Hexan, iso¬Preferred organic solvents are ethers, e.g. B. diethyl ether, dimethoxymethane, diethylene glycol dimethyl ether, tetrahydrofuran, dioxane, dioxolane, diisopropyl ether, tert-butyl methyl ether, hydrocarbons, e.g. B. hexane, iso¬
Hexan, Heptan, Cyclohexan,Toluol, Xylol, Alkohole, z. B. Methanol, Ethanol, 1- Propanol, 2-Propanol, Ethylenglykol, 1-Butanol, 2-Butanol, tert.-Butanol, Ketone, z. B. Aceton, Ethylmethylketon, iso-Butylmethylketon, Amide, z.B. Dimethylformamid, Dimethylacetamid, N-Methylpyrrolidon, Nitrile, z.B. Acetonitril, Propionitril, Butyronitril, und Mischungen derselben.Hexane, heptane, cyclohexane, toluene, xylene, alcohols, e.g. B. methanol, ethanol, 1-propanol, 2-propanol, ethylene glycol, 1-butanol, 2-butanol, tert-butanol, ketones, e.g. B. acetone, ethyl methyl ketone, iso-butyl methyl ketone, amides, e.g. Dimethylformamide, dimethylacetamide, N-methylpyrrolidone, nitriles, e.g. Acetonitrile, propionitrile, butyronitrile, and mixtures thereof.
Besonders bevorzugte organische Lösungsmittel sind Ether, wie Dimethoxyethan, Diethylenglykoldimethylether, Tetrahydrofuran, Dioxan, Diisopropylether, Kohlenwasserstoffe, wie Hexan, Heptan, Cyclohexan, Toluol, Xylol, Alkohole, wie Methanol, Ethanol, 1-Propanol, 2-Propanol, 1-Butanol, 2-Butanol, tert.-Butanol,Particularly preferred organic solvents are ethers, such as dimethoxyethane, diethylene glycol dimethyl ether, tetrahydrofuran, dioxane, diisopropyl ether, hydrocarbons, such as hexane, heptane, cyclohexane, toluene, xylene, alcohols, such as methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, tert-butanol,
Ethylenglykol, Ketone, wie Methylethylketon, iso-Butylmethylketon, Amide, wie Dimethylformamid, Dimethylacetamid, N-Methylpyrrolidon, und Mischungen derselben.Ethylene glycol, ketones such as methyl ethyl ketone, iso-butyl methyl ketone, amides such as Dimethylformamide, dimethylacetamide, N-methylpyrrolidone, and mixtures thereof.
Ganz besonders bevorzugte organische Lösungsmittel sind Ether, z. B. Dimethoxyethan, Tetrahydrofuran, Dioxan, Kohlenwasserstoffe, z. B. Cyclohexan,Very particularly preferred organic solvents are ethers, e.g. B. dimethoxyethane, tetrahydrofuran, dioxane, hydrocarbons, e.g. B. cyclohexane,
Toluol, Xylol, Alkohole, z. B. Ethanol, 1-Propanol, 2-Propanol, 1-Butanol, tert.- Butanol und Mischungen derselben.Toluene, xylene, alcohols, e.g. As ethanol, 1-propanol, 2-propanol, 1-butanol, tert-butanol and mixtures thereof.
Beispiele für die Verwendung von Wasser und organischen Lösungsmitteln sind Mischungen aus Wasser und Toluol sowie Wasser, Toluol und Tetrahydrofuran.Examples of the use of water and organic solvents are mixtures of water and toluene and water, toluene and tetrahydrofuran.
Basen, die bei dem erfindungsgemäßen Verfahren vorzugsweise Verwendung finden, sind Alkali- und Erdalkalimetallhydroxide, Alkali- undBases which are preferably used in the process according to the invention are alkali and alkaline earth metal hydroxides, alkali and
Erdalkalimetallcarbonate, Alkalimetallhydrogencarbonate, Alkali- und Erdalkalimetallacetate, Alkali- und Erdalkalimetallalkoholate, sowie primäre, sekundäre und tertiäre Amine.Alkaline earth metal carbonates, alkali metal hydrogen carbonates, alkali and alkaline earth metal acetates, alkali and alkaline earth metal alcoholates, as well as primary, secondary and tertiary amines.
Dies bedeutet, daß die eingesetzte Aminkomponente, einen entsprechendenThis means that the amine component used, a corresponding
Überschuß vorausgesetzt, auch als Base wirken kann.Provided excess can also act as a base.
Besonders bevorzugt sind Alkali- und Erdalkalimetallhydroxide, Alkali- und Erdalkalimetallcarbonate und Alkali- und Erdalkalimetallalkoholate.Alkali and alkaline earth metal hydroxides, alkali and alkaline earth metal carbonates and alkali and alkaline earth metal alcoholates are particularly preferred.
Insbesondere bevorzugt sind Alkalimetallhydroxide, wie Natriumhydroxid undAlkali metal hydroxides, such as sodium hydroxide and, are particularly preferred
Kaliumhydroxid, sowie Alkali- und Erdalkalimetallalkoholate, wie Natriumethanolat und Natrium- oder Kalium-tert.-butanolat.Potassium hydroxide, and alkali and alkaline earth metal alcoholates, such as sodium ethanolate and sodium or potassium tert-butoxide.
Die Base wird bei dem erfindungsgemäßen Verfahren bevorzugt mit einem Anteil von 50 bis 500 Mol-%, besonders bevorzugt 50 bis 250 Mol-%, ganz besonders bevorzugt 75 bis 200 Mol-%, insbesondere 90 bis 120 Mol-%, bezogen auf vorhandene Mole N-H, eingesetzt.In the process according to the invention, the base is preferably present in a proportion of 50 to 500 mol%, particularly preferably 50 to 250 mol%, very particularly preferably 75 to 200 mol%, in particular 90 to 120 mol%, based on the moles present NH, used.
Die Palladiumkomponente enthält Palladiummetall oder eine Palladium (0) oder (II)The palladium component contains palladium metal or a palladium (0) or (II)
Verbindung. Palladiumkomponente und Phosphanligand können als Komplex, z.B. als das u. a. bevorzugte Pd(PPh3)4, oder getrennt eingesetzt werden.Connection. Palladium component and phosphine ligand can be used as a complex, for example as the preferred Pd (PPh 3 ) 4 , or separately.
Als Palladiumkomponente eignen sich beispielsweise Palladiumverbindungen, wie Palladiumketonate, Palladiumacetylacetonate, Nitrilpalladiumhalogenide,Suitable palladium components are, for example, palladium compounds, such as palladium ketonates, palladium acetylacetonates, nitrile palladium halides,
Olefinpalladiumhalogenide, Palladiumhalogenide, Allylpalladiumhalogenide und Palladiumbiscarboxylate, bevorzugt Palladiumketonate, Palladiumacetylacetonate, bis-η2-Olefinpalladiumdihalogenide, Palladium(ll)halogenide, η3- Allylpalladiumhalogenid Dimere und Palladiumbiscarboxylate, ganz besonders bevorzugt Bis(dibenzylidenaceton)palladium(0) [Pd(dba)2)], Pd(dba)2 CHCI3, Pal- ladiumbisacetylacetonat, Bis(benzonitril)palladiumdichlorid, PdCI2, Na2PdCI4, Dichlorobis(dimethylsulfoxid)palladium(ll), Bis(acetonitril)palladiumdichlorid, Palladium-ll-acetat, Palladium-ll-propionat, Palladium-ll-butanoat und (1c,5c- Cyclooctadien)palladiumdichlorid.Olefin palladium halides, palladium halides, allyl palladium halides and palladium biscarboxylates, preferably palladium ketonates, palladium acetylacetonates, bis-η 2 -olefin palladium dihalides, palladium (II) halides, η 3 -allyl palladium halide dimers and palladium benzodiacid (palladium bisdibarbon) (palladium benzyl dibarbyl) (palladium bisdibidone) (palladium benzodibibone) (palladium benzodibibone) (palladium bisdibarbon) (palladium bisdibarboxylate) (especially palladium benzodibibone) (palladium bisdibarbon) (palladium bisdibarboxylate) (palladium bisdibibone) (palladium bisdibibone) (palladium bisdibarbyl) (palladium bisdibacyl) (particularly preferred 2 )], Pd (dba) 2 CHCI 3 , palladium bisacetylacetonate, bis (benzonitrile) palladium dichloride, PdCI 2 , Na 2 PdCI 4 , dichlorobis (dimethyl sulfoxide) palladium (II), bis (acetonitrile) palladium dichloride, palladium II acetate , Palladium-II-propionate, palladium-II-butanoate and (1c, 5c-cyclooctadiene) palladium dichloride.
Ebenso als Palladiumkomponente dienen kann Palladium in metallischer Form, im folgenden nur Palladium genannt, vorzugsweise Palladium in pulverisierter Form oder auf einem Trägermaterial, z.B. Palladium auf Aktivkohle, Palladium auf Aluminiumoxid, Palladium auf Bariumcarbonat, Palladium auf Bariumsulfat, Palladium auf Aluminiumsilikaten, wie Montmorillonit, Palladium auf SiO2 undPalladium can also serve as a palladium component in metallic form, hereinafter only called palladium, preferably palladium in powdered form or on a support material, for example palladium on activated carbon, palladium on aluminum oxide, palladium on barium carbonate, palladium on barium sulfate, palladium on aluminum silicates, such as montmorillonite, Palladium on SiO 2 and
Palladium auf Calciumcarbonat, jeweils mit einem Palladiumgehalt von 0,5 bis 10 Gew.-%. Besonders bevorzugt sind Palladium in pulverisierter Form, Palladium auf Aktivkohle, Palladium auf Barium- und/oder Calciumcarbonat und Palladium auf Bariumsulfat, jeweils mit einem Palladiumgehalt von 0,5 bis 10 Gew.-% insbesondere bevorzugt ist Palladium auf Aktivkohle mit einem Palladiumgehalt vonPalladium on calcium carbonate, each with a palladium content of 0.5 to 10 wt .-%. Palladium in powdered form, palladium on activated carbon, palladium on barium and / or calcium carbonate and palladium on barium sulfate, in each case with a palladium content of 0.5 to 10% by weight, are particularly preferred. Palladium on activated carbon with a palladium content of is particularly preferred
5 oder 10 Gew.-%5 or 10% by weight
Die Palladiumkomponente wird bei dem erfindungsgemäßen Verfahren mit einem Anteil von 0,01 bis 10 Mol-%, bevorzugt 0,05 bis 5 Mol-%, besonders bevorzugt 0,1 bis 3 Mol-%, insbesondere bevorzugt 0,1 bis 1 ,5 Mol-%, bezogen auf vorhandene N-In the process according to the invention, the palladium component is used in a proportion of 0.01 to 10 mol%, preferably 0.05 to 5 mol%, particularly preferably 0.1 to 3 mol%, particularly preferably 0.1 to 1.5 Mol%, based on the N-
H-Gruppen, eingesetzt. Für das erfindungsgemäße Verfahren geeignete Phosphanliganden sind beispielsweise Trialkylphosphane, Tricycloalkylphosphane, Triarylphosphane, wobei die drei Substituenten am Phosphor gleich oder verschieden, chiral oder achiral sein können und wobei einer oder mehrere der Liganden die Phosphorgruppen mehrerer Phosphane verknüpfen können und wobei ein Teil dieser Verknüpfung auch ein oder mehrere Metallatome sein können.H groups. Suitable phosphine ligands for the process according to the invention are, for example, trialkylphosphines, tricycloalkylphosphanes, triarylphosphines, where the three substituents on the phosphorus can be the same or different, chiral or achiral and one or more of the ligands can link the phosphorus groups of several phosphines and part of this linkage also includes or can be several metal atoms.
Beispiele für im Rahmen des erfindungsgemäßen Verfahrens verwendbare Phosphane sind Trimethylphosphan, Tributylphosphan, Tricyclohexylphosphan, Triphenylphosphan, Tritolylphosphan, Tris-(4-dimethylaminophenyl)-phosphan, Bis(diphenylphosphano)methan, 1 ,2-Bis(diphenylphosphano)ethan, 1 ,3-Examples of phosphanes which can be used in the process according to the invention are trimethylphosphine, tributylphosphine, tricyclohexylphosphine, triphenylphosphine, tritolylphosphine, tris (4-dimethylaminophenyl) phosphine, bis (diphenylphosphano) methane, 1,2-bis (diphenylphosphano) ethane, 1,3
Bis(diphenylphosphano)propan und 1 ,1'-Bis(diphenylphosphano)-ferrocen.Bis (diphenylphosphano) propane and 1, 1'-bis (diphenylphosphano) ferrocene.
Ganz besonders bevorzugt sind Triphenylphosphan, Tris(o-tolyl)phosphan, 1 ,2- Bis(diphenylphosphano)ethan, 1 ,3-Bis(diphenylphosphano)propan und 1 ,1'- Bis(diphenylphosphano)-ferrocen, insbesondere Triphenylphosphan und Tris(o- tolyl)phosphan.Triphenylphosphine, tris (o-tolyl) phosphane, 1,2-bis (diphenylphosphano) ethane, 1,3-bis (diphenylphosphano) propane and 1,1'-bis (diphenylphosphano) ferrocene, especially triphenylphosphane and tris, are very particularly preferred (o-tolyl) phosphine.
Für das erfindungsgemäße Verfahren weiterhin geeignet sind wasserlösliche Phosphanliganden, die beispielsweise Sulfonsäuresalz- und/oder Sulfonsäurereste und/oder Carbonsäuresalz- und/oder Carbonsäurereste und/oder Phosphonsäuresalz und/oder Phosphonsäurereste und/oder Phosphoniumgruppen und/oder Peralkylammoniumgruppen und/oder Hydroxygruppen und/oder Polyethergruppen mit geeigneter Kettenlänge enthalten.Also suitable for the process according to the invention are water-soluble phosphine ligands which contain, for example, sulfonic acid salt and / or sulfonic acid residues and / or carboxylic acid salt and / or carboxylic acid residues and / or phosphonic acid salt and / or phosphonic acid residues and / or phosphonium groups and / or peralkylammonium groups and / or hydroxyl groups and / or Contain polyether groups with a suitable chain length.
Bevorzugte Klassen von wasserlöslichen Phosphanliganden sind mit den obigen Gruppen substituierte Trialkylphosphane, Tricycloalkylphosphane, Triarylphosphane,Preferred classes of water-soluble phosphine ligands are trialkylphosphines substituted with the above groups, tricycloalkylphosphanes, triarylphosphines,
Dialkylarylphosphane, Alkyldiarylphosphane und Heteroarylphosphane wie Tripyridylphosphan und Trifurylphosphan, wobei die drei Substituenten am Phosphor gleich oder verschieden, chiral oder achiral sein können und wobei einer oder mehrere der Liganden die Phosphorgruppen mehrerer Phosphane verknüpfen können und wobei ein Teil dieser Verknüpfung auch ein oder mehrere Metallatome sein können. Der Phosphanligand wird bei dem erfindungsgemäßen Verfahren mit einem Anteil von 0,1 bis 20 Mol %, bevorzugt 0,2 bis 15 Mol %, besonders bevorzugt 0,5 bis 10 Mol %, insbesonders bevorzugt 1 bis 6 Mol %, bezogen auf vorhandene N-H- Gruppen, eingesetzt.Dialkylarylphosphanes, alkyldiarylphosphanes and heteroarylphosphines such as tripyridylphosphine and trifurylphosphine, where the three substituents on the phosphorus may be the same or different, chiral or achiral and where one or more of the ligands may link the phosphorus groups of several phosphines and part of this linkage may also be one or more metal atoms can. In the process according to the invention, the phosphine ligand is used in a proportion of 0.1 to 20 mol%, preferably 0.2 to 15 mol%, particularly preferably 0.5 to 10 mol%, particularly preferably 1 to 6 mol%, based on the NH present - Groups.
Es können gegebenenfalls auch Mischungen zweier oder mehrerer verschiedener Phosphanliganden eingesetzt werden.Mixtures of two or more different phosphine ligands can optionally also be used.
Die Produkte des erfindungsgemäßen Verfahrens eignen sich z.B. zur Verwendung in Elektrolumineszenzvorrichtungen, farbstoffsensibilisierten photovoltaischen Zellen oder in der Xerographie, beispielsweise als Lochleitermaterialien.The products of the method according to the invention are e.g. for use in electroluminescent devices, dye-sensitized photovoltaic cells or in xerography, for example as hole conductor materials.
Die Erfindung wird durch die nachfolgenden Beispiele näher erläutert, ohne sie dadurch einschränken zu wollen.The invention is explained in more detail by the following examples, without wishing to restrict it thereby.
Beispiel 1 :Example 1 :
Herstellung von 2,2',7,7'-Tetrakis(N,N-diphenylamino)-spiro-9,9'-bifluoren-Bifluoren Preparation of 2,2 ', 7,7'-tetrakis (N, N-diphenylamino) -spiro-9,9'
2,2',7,7'-Tetrabrom-9,9'-spirobifluoren (20,86 g, 33 mmol) und Diphenylamin (25,38 g, 150 mmol) wurden in Toluol (400 ml) vorgelegt und die Lösung mit N2 gesättigt.2.2 ' , 7.7 ' tetrabromo-9.9 ' spirobifluorene (20.86 g, 33 mmol) and diphenylamine (25.38 g, 150 mmol) were placed in toluene (400 ml) and the solution with N 2 saturated.
Anschließend gab man Pd(OAc)2 (311 mg, 1 ,5 mmol), P(o-Tolyl)3 (0,913 g, 3 mmol) und die Base (NaO'Bu, 20,18 g, 210 mmol) zu. Die Lösung färbte sich sofort dunkelgrün. Es wurde für 72 Stunden unter Rückfluß gerührt.Then Pd (OAc) 2 (311 mg, 1.5 mmol), P (o-tolyl) 3 (0.913 g, 3 mmol) and the base (NaO'Bu, 20.18 g, 210 mmol) were added. The solution immediately turned dark green. It was stirred under reflux for 72 hours.
Nach Abkühlen des Ansatzes auf Raumtemperatur wurde NaCN-Lösung zugeben (ca 2 g NaCN in 200 ml Wasser) und ca. 60 min gerührt. Anschließend wurde dreimal mit Wasser gewaschen. Die organische Phase wurde über Na2SO4 getrocknet und das Lösungsmittel anschließend abgezogen. Man erhielt hellbrauneAfter the mixture had cooled to room temperature, NaCN solution was added (about 2 g of NaCN in 200 ml of water) and the mixture was stirred for about 60 min. It was then washed three times with water. The organic phase was dried over Na 2 SO 4 and the solvent was then stripped off. Light brown was obtained
Kristalle.Crystals.
Diese wurden in 100 ml Dioxan und 5 ml Hydrazinhydrat umkristallisiert. Dieser Vorgang wurde einmal wiederholt. Schließlich wurden die erhaltenen Kristalle mehrfach mit Hexan ausgerührt und im Vakuum bei 60°C getrocknet. Man erhielt 19.3 g (59%) farbloses Pulver, welches gemäß HPLC eine Reinheit von größer 99.7% aufwies.These were recrystallized from 100 ml of dioxane and 5 ml of hydrazine hydrate. This process was repeated once. Finally, the crystals obtained were stirred several times with hexane and dried in vacuo at 60 ° C. 19.3 g (59%) of colorless powder were obtained which, according to HPLC, had a purity of greater than 99.7%.
1H NMR (CDCI3, NH2NH2*H2O): δ [ppm] = 7.45 (d, 4H, H-4, J = 8 Hz), 7.19 (m, 16 H, H-3'), 6.97 (m, 24 H, H-2\ H-4'), 6.92 (dd, 4 H, H-3, J, = 2, J2 = 8 Hz), 6.69 (d, 4 H, 1 H NMR (CDCI 3 , NH 2 NH 2 * H 2 O): δ [ppm] = 7.45 (d, 4H, H-4, J = 8 Hz), 7.19 (m, 16 H, H-3 ') , 6.97 (m, 24 H, H-2 \ H-4 '), 6.92 (dd, 4 H, H-3, J, = 2, J 2 = 8 Hz), 6.69 (d, 4 H,
H-1 , J = 2 Hz).H-1, J = 2 Hz).
Die Verwendung von DPPF (Bis(diphenylphosphino)ferrocen) als Ligand führte zu einer Ausbeuteverschlechterung (45%; Reinheit: >99.9%), die Verwendung von BINAP (2,2'-Bis(diphenylphosphino)-1 ,1'-binaphthyl) hingegen zu einer leichtenThe use of DPPF (bis (diphenylphosphino) ferrocene) as a ligand led to a deterioration in yield (45%; purity:> 99.9%), the use of BINAP (2,2'-bis (diphenylphosphino) -1, 1'-binaphthyl) however, to an easy one
Ausbeutesteigerung (62%; Reinheit: >99.7%).Increased yield (62%; purity:> 99.7%).
Beispiel 2:Example 2:
Herstellung von 2,2',7,7'-Tetrakis(N,N-di-4-methoxyphenylamino)-spiro-9,9'-bifluoren-Bifluoren Preparation of 2,2 ', 7,7'-tetrakis (N, N-di-4-methoxy-phenylamino) -spiro-9,9'
2,2',7,7'-Tetrabrom-9,9'-spirobifluoren (13.9 g, 22 mmol) und 4,4'- Dimethoxydiphenylamin (22.98 g, 100 mmol) wurden in Toluol (250 ml) gelöst und die Lösung mit N2 gesättigt. Die Lösung verfärbte sich braun. Anschließend gab man Pd(OAc)2 (223 mg, 1 mmol) und P(o-Tolyl)3 (608 mg, 2 mmol) zu. NaO'Bu (13.5 g, 140 mmol) wurde als Lösung in Dioxan (in 150ml) zugetropft. Die Lösung färbte sich beim Zutropfen langsam dunkelbraun. Die Lösung wurde unter Schutzgas für 72 Stunden am Rückfluß gerührt.2,2 ' , 7,7 ' tetrabromo-9,9 ' spirobifluorene (13.9 g, 22 mmol) and 4,4'-dimethoxydiphenylamine (22.98 g, 100 mmol) were dissolved in toluene (250 ml) and the solution saturated with N 2 . The solution turned brown. Then Pd (OAc) 2 (223 mg, 1 mmol) and P (o-tolyl) 3 (608 mg, 2 mmol) were added. NaO'Bu (13.5 g, 140 mmol) was added dropwise as a solution in dioxane (in 150 ml). The solution slowly turned dark brown when added dropwise. The solution was stirred under reflux under protective gas for 72 hours.
Nach Abkühlen auf Raumtemperatur wurde mit H2O hydrolysiert, die Wasserphase abgetrennt, mit NaCN-Lösung (3 g NaCN in 300ml Wasser) 2h ausgerührt und anschließend erneut die Wasserphase abgetrennt. Die organische Phase wurde filtriert und das Lösungsmittel abgezogen. Man erhielt ein schwarzes Öl , das mit der Zeit erstarrte. Es wurde in 50 ml Dioxan heiß gelöst in der Wärme mit 50 ml Ethanol versetzt und unter Rühren abgekühlt. Dabei fiel ein gelb-grüner Feststoff aus. Dieser wurde abgesaugt und mehrmals mit kleinen Portionen (je 2 ml) Dioxan nachgewaschen; bis die Farbe hellgelb war. Anschließend wurde nochmals aus ganz wenig Dioxan umkristallisiert (Zusatz von einigen Tropfen Hydrazinhydrat). Es wurden 13.9 g (52%) fast farbloses Pulver erhalten, welches laut 1H-NMR eine Reinheit von 99% aufwies.After cooling to room temperature, hydrolysis was carried out with H 2 O, the water phase was separated off, stirred with NaCN solution (3 g of NaCN in 300 ml of water) for 2 hours and then the water phase was separated off again. The organic phase was filtered and the solvent was removed. A black oil was obtained which solidified over time. It was dissolved hot in 50 ml of dioxane, mixed with 50 ml of ethanol in the heat and cooled with stirring. A yellow-green solid precipitated out. This was suctioned off and washed several times with small portions (2 ml each) of dioxane; until the color was light yellow. The mixture was then recrystallized again from very little dioxane (addition of a few drops of hydrazine hydrate). 13.9 g (52%) of almost colorless powder were obtained, which had a purity of 99% according to 1 H-NMR.
1H NMR (CDCI3, NH2NH2*H2O): δ [ppm] = 7.36 (d, 4H, H-4, J = 8 Hz), 6.90 + 6.75 (AA'BB', jeweils 16 H, H-2', H-3"), 6.79 (dd, 4 H, H-3, J, = 2, J2 = 8 Hz), 6.55 (d, 4 H, H-1 , J = 2 Hz), 3.77 (s, 24 H, OMe). 1 H NMR (CDCI 3 , NH 2 NH 2 * H 2 O): δ [ppm] = 7.36 (d, 4H, H-4, J = 8 Hz), 6.90 + 6.75 (AA'BB ', each 16 H , H-2 ', H-3 "), 6.79 (dd, 4 H, H-3, J, = 2, J 2 = 8 Hz), 6.55 (d, 4 H, H-1, J = 2 Hz ), 3.77 (s, 24 H, OMe).
Beispiel 3:Example 3:
Herstellung von 2,2',7,7'-Tetrakis(N-phenothiazinyl)-spiro-9,9'-bifluorenPreparation of 2,2 ', 7,7'-tetrakis (N-phenothiazinyl) -spiro-9,9 ' -bifluorene
Die Umsetzung wurde analog zu Beispiel 2 durchgeführt. Bei der Aufarbeitung wurde nach Ausrühren mit NaCN-Lösung der entstandene Feststoff abgesaugt. Der erhaltene Feststoff wurde zunächst mit Aceton : Wasser : Hydrazinhydrat (70:15:3) ca. 1 Stunde ausgekocht und schließlich aus Chloroform : Ethanol (1 :1 ) umkristallisiert. Man erhielt das reine Produkt (laut 1H-NMR Reinheit >99%) als farbloses Pulver: 47% Ausbeute.The reaction was carried out analogously to Example 2. In the workup, the solid formed was filtered off with suction after stirring with NaCN solution. The solid obtained was first boiled for about 1 hour with acetone: water: hydrazine hydrate (70: 15: 3) and finally recrystallized from chloroform: ethanol (1: 1). The pure product (according to 1 H-NMR purity> 99%) was obtained as a colorless powder: 47% yield.
1H NMR (CDCI3, NH2NH2*H2O): δ [ppm] = 8.06 (d, 4H, H-4, J = 8 Hz), 7.43 (dd, 4 H, H-3, J, = 2, J2 = 8 Hz), 7.08 (d, 4 H, H-1 , J = 2 Hz), 6.96 (dd, 4 H, H-4', J, = 1.5, J2 = 7.5 Hz), 6.71 (dt, 4 H, H-3', J, = 1.2, J2 = 7.5 Hz), 6.47 (ddd, 4 H, H-2', J, = 1.5, J2 = 7.3 Hz, J3 = 8.3 Hz), 5.98 (dd, 4 H, H-1 \ J, = 1.0, J2 = 8.3 Hz). 1 H NMR (CDCI 3 , NH 2 NH 2 * H 2 O): δ [ppm] = 8.06 (d, 4H, H-4, J = 8 Hz), 7.43 (dd, 4 H, H-3, J , = 2, J 2 = 8 Hz), 7.08 (d, 4 H, H-1, J = 2 Hz), 6.96 (dd, 4 H, H-4 ', J, = 1.5, J 2 = 7.5 Hz ), 6.71 (dt, 4 H, H-3 ', J, = 1.2, J 2 = 7.5 Hz), 6.47 (ddd, 4 H, H-2', J, = 1.5, J 2 = 7.3 Hz, J 3 = 8.3 Hz), 5.98 (dd, 4 H, H-1 \ J, = 1.0, J 2 = 8.3 Hz).
Beispiel 4:Example 4:
Herstellung von 2,2',7,7'-Tetrakis(N,N-di-4-methylphenylamino)-spiro-9,9'-bifluoren-Bifluoren Preparation of 2,2 ', 7,7'-tetrakis (N, N-di-4-methylphenylamino) -spiro-9,9'
2,2',7,7'-Tetrabrom-9,9'-spirobifluoren und 4,4'-Dimethyldiphenylamin wurden analog zu Beispiel 2 umgesetzt. Die Aufarbeitung erfolgte ebenfalls analog. Nach Trocknung erhielt man 51 % Produkt (Reinheit: >99.5% nach NMR).2,2 ' , 7,7 ' tetrabromo-9,9 ' spirobifluorene and 4,4'-dimethyldiphenylamine were reacted analogously to Example 2. The processing was also carried out analogously. After drying, 51% of the product was obtained (purity:> 99.5% by NMR).
1H NMR (CDCI3, NH2NH2*H2O): δ [ppm] = 7.39 (d, 4H, H-4, J = 8 Hz), 6.99 + 6.88 (AA'BB', jeweils 16 H, H-2', H-3'), 6.85 (dd, 4 H, H-3, J1 = 2, J2 = 8 Hz), 6.66 (d, 4 H, 1 H NMR (CDCI 3 , NH 2 NH 2 * H 2 O): δ [ppm] = 7.39 (d, 4H, H-4, J = 8 Hz), 6.99 + 6.88 (AA'BB ', each 16 H , H-2 ', H-3'), 6.85 (dd, 4 H, H-3, J 1 = 2, J 2 = 8 Hz), 6.66 (d, 4 H,
H-1 , J = 2 Hz), 2.29 (s, 24 H, Me). Beispiel 5:H-1, J = 2 Hz), 2.29 (s, 24 H, Me). Example 5:
Herstellung von 2,2',7,7'-Tetrakis(N-phenyl-N-(3-methylphenyl)amino)-spiro-9,9'- bifluorenPreparation of 2,2 ', 7,7'-tetrakis (N-phenyl-N- (3-methylphenyl) amino) -spiro-9,9' - bifluorene
2,2',7,7'-Tetrabrom-9,9'-spirobifluoren und 3-Methyldiphenylamin wurden analog zu2,2 ', 7,7'-tetrabromo-9,9 ' -spirobifluorene and 3-methyldiphenylamine were analogous to
Beispiel 1 umgesetzt. Als Ligand wurde DPPF verwendet. Die Aufarbeitung erfolgte ebenfalls analog, jedoch erwies sich das Produkt als deutlich schwerer reinigbar. So wurde zunächst zweimal über eine Kieselgelsäule filtriert und anschließend zunächst aus Ethylacetat/Methanol (2:1), dann mehrfach aus Dioxan umkristallisiert. Nach Trocknung erhielt man 26% Produkt (Reinheit: >99.9% nach HPLC).Example 1 implemented. DPPF was used as the ligand. The workup was also carried out analogously, but the product proved to be significantly more difficult to clean. The mixture was first filtered twice over a silica gel column and then initially recrystallized from ethyl acetate / methanol (2: 1), then repeatedly from dioxane. After drying, 26% product was obtained (purity:> 99.9% according to HPLC).
1H NMR (CDCI3, NH2NH2 *H2O): δ [ppm] = 7.43 (d, 4H, H-4, J = 8 Hz), 7.18 + 6.97 + 6.94 (AA'BB'C, 8 + 8 + 4 H, H-3', H-2', H-4'), 7.08 (t, 4 H, H-5", J = 7 Hz), 6.89 (dd, 4 H, H-3, J, = 2, J2 = 8 Hz), 6.84 (s (br), 4 H, H-2"), 6.78 (m, 8 H, H-4", H-6"), 6.68 (d, 4 H, H-1 , J = 2 Hz), 2.22 (s, 12 H, Me). 1 H NMR (CDCI 3 , NH 2 NH 2 * H 2 O): δ [ppm] = 7.43 (d, 4H, H-4, J = 8 Hz), 7.18 + 6.97 + 6.94 (AA'BB'C, 8 + 8 + 4 H, H-3 ', H-2', H-4 '), 7.08 (t, 4 H, H-5 ", J = 7 Hz), 6.89 (dd, 4 H, H- 3, J, = 2, J 2 = 8 Hz), 6.84 (s (br), 4 H, H-2 "), 6.78 (m, 8 H, H-4", H-6 "), 6.68 ( d, 4 H, H-1, J = 2 Hz), 2.22 (s, 12 H, Me).
Beispiel 6:Example 6:
Herstellung von 2,2',7,7'-Tetrakis(N,N-di-4-biphenylamino)-spiro-9,9'-bifluoren-Bifluoren Preparation of 2,2 ', 7,7'-tetrakis (N, N-di-4-biphenylamino) -spiro-9,9'
2,2',7,7'-Tetrabrom-9,9'-spirobifluoren und 4,4'-Biphenylamin wurden analog zu2,2 ' , 7,7 ' tetrabromo-9,9 ' spirobifluorene and 4,4'-biphenylamine were analogous to
Beispiel 2 umgesetzt. Die Aufarbeitung erfolgte ebenfalls analog. Nach Trocknung erhielt man 31% Produkt (Reinheit: >99.7% nach HPLC).Example 2 implemented. The processing was also carried out analogously. After drying, 31% of product was obtained (purity:> 99.7% according to HPLC).
1H NMR (CDCI3, NH2NH2Η2O): δ [ppm] = 7.53 (d, 4H, H-4, J = 8 Hz), 7.51 + 7.37 + 7.28 (AA'BB'C, 16 + 16 + 8 H, H-2", H-3", H-4"), 7.42 + 7.12 (AA'BB', jeweils 16 H, 1 H NMR (CDCI 3 , NH 2 NH 2 Η 2 O): δ [ppm] = 7.53 (d, 4H, H-4, J = 8 Hz), 7.51 + 7.37 + 7.28 (AA'BB'C, 16 + 16 + 8 H, H-2 ", H-3", H-4 "), 7.42 + 7.12 (AA'BB ', each 16 H,
H-2', H-3'), 7.03 (dd, 4 H, H-3, J, = 2, J2 = 8 Hz), 6.86 (d, 4 H, H-1 , J = 2 Hz). Beispiel 7:H-2 ', H-3'), 7.03 (dd, 4 H, H-3, J, = 2, J 2 = 8 Hz), 6.86 (d, 4 H, H-1, J = 2 Hz) . Example 7:
Herstellung von 2,2',7,7'-Tetrakis(N-phenyl-N-(2-naphthyl)amino)-spiro-9,9'-bifluorenPreparation of 2,2 ', 7,7'-tetrakis (N-phenyl-N- (2-naphthyl) amino) -spiro-9,9'-bifluorene
2,2',7,7'-Tetrabrom-9,9'-spirobifluoren und 2-Naphthylphenylamin wurden analog zu Beispiel 5 umgesetzt. Die Aufarbeitung erfolgte ebenfalls analog, das Produkt erwies sich ebenfalls als schwer reinigbar. So wurde zunächst zweimal über eine Kieselgelsäule filtriert und dann mehrfach aus Dioxan/Methanol umkristallisiert. Nach Trocknung erhielt man 35% Produkt (Reinheit: >99.7% nach HPLC).2,2 ', 7,7 ' tetrabromo-9,9'-spirobifluorene and 2-naphthylphenylamine were reacted analogously to Example 5. The workup was also carried out analogously, the product also proved to be difficult to clean. The mixture was first filtered twice over a silica gel column and then recrystallized several times from dioxane / methanol. After drying, 35% product was obtained (purity:> 99.7% according to HPLC).
1H NMR (CDCI3, NH2NH2*H2O): δ [ppm] = 7.75 (dd, 4 H, H-5NP, J, = 2, J2 = 7 Hz), 1 H NMR (CDCI 3 , NH 2 NH 2 * H 2 O): δ [ppm] = 7.75 (dd, 4 H, H-5 NP , J, = 2, J 2 = 7 Hz),
7.67 (d, 4 H, H-4NP, J = 9 Hz), 7.53 (dd, 4 H, H-8NP, J, = 2, J2 = 7.5 Hz), 7.44 (d, 4H, H-4, J = 8 Hz), 7.35 (m, 12 H, H-1NP, H-6NP, H-7NP), 7.23 + 7.08 + 7.03 (AA'BB'C, 8 + 8 + 4 H, H-3PH, H-2PH, H-4PH), 7.19 (dd, 4 H, H-3NP, = 2, J2 = 8.8 Hz), 6.95 (dd, 4 H, H-3, J, = 2, J2 = 8 Hz), 6.76 (d, 4 H, H-1 , J = 2 Hz). 7.67 (d, 4 H, H-4 NP , J = 9 Hz), 7.53 (dd, 4 H, H-8 NP , J, = 2, J 2 = 7.5 Hz), 7.44 (d, 4H, H- 4, J = 8 Hz), 7.35 (m, 12 H, H-1 NP , H-6 NP , H-7 NP ), 7.23 + 7.08 + 7.03 (AA'BB'C, 8 + 8 + 4 H, H-3 PH , H-2 PH , H-4 PH ), 7.19 (dd, 4 H, H-3 NP , = 2, J 2 = 8.8 Hz), 6.95 (dd, 4 H, H-3, J, = 2, J 2 = 8 Hz), 6.76 (d, 4 H, H-1, J = 2 Hz).
Claims
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000510701A JP2001515879A (en) | 1997-09-05 | 1998-08-26 | Preparation of aryl oligoamines |
| DE59813182T DE59813182D1 (en) | 1997-09-05 | 1998-08-26 | PROCESS FOR PREPARING ARYLOLIGOAMINES |
| EP98946429A EP1009731B1 (en) | 1997-09-05 | 1998-08-26 | Method for producing aryloligoamines |
| US09/486,867 US6476265B1 (en) | 1997-09-05 | 1998-08-26 | Method for producing aryl oligoamines |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19738860A DE19738860A1 (en) | 1997-09-05 | 1997-09-05 | Process for the preparation of aryl oligoamines |
| DE19738860.4 | 1997-09-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1999012888A1 true WO1999012888A1 (en) | 1999-03-18 |
Family
ID=7841314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP1998/005398 Ceased WO1999012888A1 (en) | 1997-09-05 | 1998-08-26 | Method for producing aryloligoamines |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US6476265B1 (en) |
| EP (1) | EP1009731B1 (en) |
| JP (1) | JP2001515879A (en) |
| DE (2) | DE19738860A1 (en) |
| WO (1) | WO1999012888A1 (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002076922A1 (en) * | 2001-03-16 | 2002-10-03 | Idemitsu Kosan Co., Ltd. | Method for producing aromatic amino compound |
| WO2003037844A1 (en) * | 2001-10-30 | 2003-05-08 | Covion Organic Semiconductors Gmbh | Method for the production of arylamines |
| US7223484B2 (en) | 2002-06-29 | 2007-05-29 | Merck Patent Gmbh | 2,1,3-benzothiadiazoles for use as electronic active components |
| US7880379B2 (en) | 2003-11-25 | 2011-02-01 | Merck Patent Gmbh | Phosphorescent organic electroluminescent device having no hole transporting layer |
| EP2281861A2 (en) | 2003-04-15 | 2011-02-09 | Merck Patent GmbH | Mixture of organic emission-enabled semiconductors and matrix materials, use of same and electronic components containing same |
| US7910687B2 (en) | 2002-10-25 | 2011-03-22 | Merck Patent Gmbh | Conjugated polymers containing arylamine units, the representation thereof and the use of the same |
| US7989071B2 (en) | 2004-05-04 | 2011-08-02 | Merck Patent Gmbh | Organic electronic devices |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19942394C1 (en) | 1999-09-06 | 2001-02-01 | Bayer Ag | Increasing the yield of nitrodiphenylamines in base/palladium-catalysed nitrohalobenzene/aromatic amine reactions by using a base which has been milled and optionally also dried |
| JP4798138B2 (en) * | 2001-07-25 | 2011-10-19 | 東レ株式会社 | Light emitting element |
| JP3848224B2 (en) * | 2002-08-27 | 2006-11-22 | キヤノン株式会社 | Spiro compound and organic light emitting device using the same |
| DE102004031000A1 (en) * | 2004-06-26 | 2006-01-12 | Covion Organic Semiconductors Gmbh | Organic electroluminescent devices |
| JP2006335712A (en) * | 2005-06-03 | 2006-12-14 | Nagoya Industrial Science Research Inst | Method for producing triarylamine |
| DE102009032922B4 (en) * | 2009-07-14 | 2024-04-25 | Merck Patent Gmbh | Materials for organic electroluminescent devices, processes for their preparation, their use and electronic device |
| US9748492B2 (en) | 2012-11-02 | 2017-08-29 | Idemitsu Kosan Co., Ltd. | Organic electroluminescent device |
| CN103013498B (en) * | 2012-12-29 | 2015-02-18 | 上海师范大学 | Application of 2,7-di(triphenylamine diamine) spirobifluorene |
| JP7261945B1 (en) * | 2021-05-24 | 2023-04-20 | 日本精化株式会社 | Hole-transporting material, precursor for synthesizing hole-transporting material and method for producing hole-transporting material |
| CN115286520A (en) * | 2022-08-19 | 2022-11-04 | 黑龙江省科学院石油化学研究院 | Preparation method of hole transport material Spiro-OMeTAD |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0611148A1 (en) * | 1993-02-10 | 1994-08-17 | Yasuhiko Shirota | Trisarylaminobenzene derivatives, compounds for organic EL element, and organic EL element |
| US5576460A (en) * | 1994-07-27 | 1996-11-19 | Massachusetts Institute Of Technology | Preparation of arylamines |
| EP0802173A1 (en) * | 1996-04-19 | 1997-10-22 | Tosoh Corporation | Process for producing heterocylic aromatic amine or arylamine |
| EP0846676A1 (en) * | 1996-12-04 | 1998-06-10 | Hoechst Aktiengesellschaft | Process for the preparation of aromatic amines from aryl chlorides |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3419534B2 (en) * | 1993-02-10 | 2003-06-23 | 靖彦 城田 | Trisarylaminobenzene derivative, compound for organic EL device and organic EL device |
| EP0676461B1 (en) * | 1994-04-07 | 2002-08-14 | Covion Organic Semiconductors GmbH | Spiro compounds and their application as electroluminescence materials |
-
1997
- 1997-09-05 DE DE19738860A patent/DE19738860A1/en not_active Withdrawn
-
1998
- 1998-08-26 EP EP98946429A patent/EP1009731B1/en not_active Expired - Lifetime
- 1998-08-26 JP JP2000510701A patent/JP2001515879A/en active Pending
- 1998-08-26 US US09/486,867 patent/US6476265B1/en not_active Expired - Lifetime
- 1998-08-26 WO PCT/EP1998/005398 patent/WO1999012888A1/en not_active Ceased
- 1998-08-26 DE DE59813182T patent/DE59813182D1/en not_active Expired - Lifetime
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0611148A1 (en) * | 1993-02-10 | 1994-08-17 | Yasuhiko Shirota | Trisarylaminobenzene derivatives, compounds for organic EL element, and organic EL element |
| US5576460A (en) * | 1994-07-27 | 1996-11-19 | Massachusetts Institute Of Technology | Preparation of arylamines |
| EP0802173A1 (en) * | 1996-04-19 | 1997-10-22 | Tosoh Corporation | Process for producing heterocylic aromatic amine or arylamine |
| EP0846676A1 (en) * | 1996-12-04 | 1998-06-10 | Hoechst Aktiengesellschaft | Process for the preparation of aromatic amines from aryl chlorides |
Non-Patent Citations (1)
| Title |
|---|
| BARAÑANO ET AL.: "Nickel and Palladium-Catalyzed Cross-Couplings that Form Carbon-Heteroatom and Carbon-element Bonds", CURRENT ORGANIC CHEMISTRY, vol. 1, no. 3, 1997, pages 287 - 305, XP002085730 * |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002076922A1 (en) * | 2001-03-16 | 2002-10-03 | Idemitsu Kosan Co., Ltd. | Method for producing aromatic amino compound |
| US7250532B2 (en) | 2001-03-16 | 2007-07-31 | Idemitsu Kosan Co., Ltd. | Method for producing aromatic amino compound |
| WO2003037844A1 (en) * | 2001-10-30 | 2003-05-08 | Covion Organic Semiconductors Gmbh | Method for the production of arylamines |
| US7250519B2 (en) | 2001-10-30 | 2007-07-31 | Merck Patent Gmbh | Method for the production of arylamines |
| US7223484B2 (en) | 2002-06-29 | 2007-05-29 | Merck Patent Gmbh | 2,1,3-benzothiadiazoles for use as electronic active components |
| US7910687B2 (en) | 2002-10-25 | 2011-03-22 | Merck Patent Gmbh | Conjugated polymers containing arylamine units, the representation thereof and the use of the same |
| EP2281861A2 (en) | 2003-04-15 | 2011-02-09 | Merck Patent GmbH | Mixture of organic emission-enabled semiconductors and matrix materials, use of same and electronic components containing same |
| US7880379B2 (en) | 2003-11-25 | 2011-02-01 | Merck Patent Gmbh | Phosphorescent organic electroluminescent device having no hole transporting layer |
| US7989071B2 (en) | 2004-05-04 | 2011-08-02 | Merck Patent Gmbh | Organic electronic devices |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1009731A1 (en) | 2000-06-21 |
| DE19738860A1 (en) | 1999-03-11 |
| US6476265B1 (en) | 2002-11-05 |
| JP2001515879A (en) | 2001-09-25 |
| DE59813182D1 (en) | 2005-12-15 |
| EP1009731B1 (en) | 2005-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1009731B1 (en) | Method for producing aryloligoamines | |
| EP1442007B1 (en) | Method for the production of arylamines | |
| DE112013001975T5 (en) | Platinum (II) complexes for OLED applications | |
| DE2238628A1 (en) | METHOD FOR PRODUCING FURAN COMPOUNDS | |
| EP0385210B1 (en) | Amidation of pyridines | |
| EP0497734A1 (en) | Process for the preparation of 2-(2',4'-dihydroxyphenyl)-4,6-diaryl-s-triazines | |
| EP0184981B1 (en) | Pyrrolinones and their intermediate products | |
| DD262024A5 (en) | PROCESS FOR THE PREPARATION OF ANILINO FUMARATES AND CHINOLIN-2,3-DICARBONE ACIDS | |
| DE60120139T2 (en) | METHOD FOR THE PRODUCTION OF CAMPTOTHECIN | |
| CH616416A5 (en) | ||
| CH630902A5 (en) | Process for preparing novel derivatives of 1,2,3,4,4a,10b-hexahydrobenzo(f)isoquinoline. | |
| DE102018003995B4 (en) | One-step triphenylazulene synthesis by dimerization of diphenylethynes | |
| DE10002561A1 (en) | Production of di- or triarylamines by reacting an aryl halide with a mono- or diarylamine comprises using a catalyst comprising a palladium compound and a tertiary phosphine | |
| DE2654795C2 (en) | Process for the preparation of aromatically substituted sulfamoylbenzoic acid derivatives | |
| DE19963009A1 (en) | Arylamine preparation in high yield, for use as intermediate for e.g. drugs or pesticides, from aryl halide and aniline or diphenylamine derivative over catalyst comprising palladium compound and tris-(silyl)-phosphine | |
| DE1097995B (en) | Process for the preparation of phenthiazine derivatives | |
| DE102004029695A1 (en) | Preparation of arylamine, useful as intermediates in e.g. pesticides, comprises reacting arylhalogenide compounds with amino compounds in the presence of organic or inorganic base and catalyst (palladium and phosphine compounds) | |
| DE2406972A1 (en) | PROCESS FOR THE PREPARATION OF 5-SULFA-MOYLANTHRANILIC ACIDS | |
| DE2107914A1 (en) | Perfluoroalkane sulphonamides - from sulphonic acid fluorides and aminophenylalkyl- amines | |
| EP0005174B1 (en) | 2-methyl-5-(2-hydroxystyryl)-1.3.4-thiadiazole and its preparation | |
| DE905244C (en) | Process for the production of new thioether and their quaternary and acid salts | |
| EP0345464A2 (en) | Process for the preparation of substituted 3-amino-2-(benzoyl)acrylic acid esters as well as a process for the preparation of intermediates for antibacterial active agents from these compounds | |
| DE1643209A1 (en) | 5H-dibenzo [a, d] cycloheptene derivatives | |
| DE959097C (en) | Process for the preparation of basic substituted diarylacetonitriles | |
| DE881662C (en) | Process for the preparation of aminoalkyl ethers of diaryl carbinols |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 1998946429 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 09486867 Country of ref document: US |
|
| WWP | Wipo information: published in national office |
Ref document number: 1998946429 Country of ref document: EP |
|
| WWG | Wipo information: grant in national office |
Ref document number: 1998946429 Country of ref document: EP |

